Literature DB >> 35277418

TLR Signaling Rescues Fungicidal Activity in Syk-Deficient Neutrophils.

Adam L Viens1, Kyle D Timmer2, Natalie J Alexander2, Rana Barghout3,4, Jelena Milosevic3,4,5, Alex Hopke5,6,7, Natalie J Atallah2,5, Allison K Scherer2,5, David B Sykes3,4,5, Daniel Irimia5,6,7, Michael K Mansour1,5.   

Abstract

An impaired neutrophil response to pathogenic fungi puts patients at risk for fungal infections with a high risk of morbidity and mortality. Acquired neutrophil dysfunction in the setting of iatrogenic immune modulators can include the inhibition of critical kinases such as spleen tyrosine kinase (Syk). In this study, we used an established system of conditionally immortalized mouse neutrophil progenitors to investigate the ability to augment Syk-deficient neutrophil function against Candida albicans with TLR agonist signaling. LPS, a known immunomodulatory molecule derived from Gram-negative bacteria, was capable of rescuing effector functions of Syk-deficient neutrophils, which are known to have poor fungicidal activity against Candida species. LPS priming of Syk-deficient mouse neutrophils demonstrates partial rescue of fungicidal activity, including phagocytosis, degranulation, and neutrophil swarming, but not reactive oxygen species production against C. albicans, in part due to c-Fos activation. Similarly, LPS priming of human neutrophils rescues fungicidal activity in the presence of pharmacologic inhibition of Syk and Bruton's tyrosine kinase (Btk), both critical kinases in the innate immune response to fungi. In vivo, neutropenic mice were reconstituted with wild-type or Syk-deficient neutrophils and challenged i.p. with C. albicans. In this model, LPS improved wild-type neutrophil homing to the fungal challenge, although Syk-deficient neutrophils did not persist in vivo, speaking to its crucial role on in vivo persistence. Taken together, we identify TLR signaling as an alternate activation pathway capable of partially restoring neutrophil effector function against Candida in a Syk-independent manner.
Copyright © 2022 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35277418      PMCID: PMC8976732          DOI: 10.4049/jimmunol.2100599

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

Review 1.  The SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDL.

Authors:  Yury I Miller; Soo-Ho Choi; Philipp Wiesner; Yun Soo Bae
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

2.  Estrogen-dependent E2a/Pbx1 myeloid cell lines exhibit conditional differentiation that can be arrested by other leukemic oncoproteins.

Authors:  D B Sykes; M P Kamps
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

3.  The RIG-I-like helicase receptor MDA5 (IFIH1) is involved in the host defense against Candida infections.

Authors:  Martin Jaeger; Robin van der Lee; Shih-Chin Cheng; Melissa D Johnson; Vinod Kumar; Aylwin Ng; Theo S Plantinga; Sanne P Smeekens; Marije Oosting; Xinhui Wang; Winfried Barchet; Kate Fitzgerald; Leo A B Joosten; John R Perfect; Cisca Wijmenga; Frank L van de Veerdonk; Martijn A Huynen; Ramnik J Xavier; Bart-Jan Kullberg; Mihai G Netea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-13       Impact factor: 3.267

4.  TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase.

Authors:  Jie Fan; Randall S Frey; Asrar B Malik
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

5.  Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients.

Authors:  Elliott Geoffrey Playford; Jeff Lipman; Masrura Kabir; Emma S McBryde; Graeme R Nimmo; Anna Lau; Tania C Sorrell
Journal:  Intensive Care Med       Date:  2009-09-15       Impact factor: 17.440

6.  Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.

Authors:  R I Lehrer; M J Cline
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

7.  Two independent killing mechanisms of Candida albicans by human neutrophils: evidence from innate immunity defects.

Authors:  Roel P Gazendam; John L van Hamme; Anton T J Tool; Michel van Houdt; Paul J J H Verkuijlen; Martin Herbst; Johannes G Liese; Frank L van de Veerdonk; Dirk Roos; Timo K van den Berg; Taco W Kuijpers
Journal:  Blood       Date:  2014-06-19       Impact factor: 22.113

8.  Population-Based Active Surveillance for Culture-Confirmed Candidemia - Four Sites, United States, 2012-2016.

Authors:  Mitsuru Toda; Sabrina R Williams; Elizabeth L Berkow; Monica M Farley; Lee H Harrison; Lindsay Bonner; Kaytlynn M Marceaux; Rosemary Hollick; Alexia Y Zhang; William Schaffner; Shawn R Lockhart; Brendan R Jackson; Snigdha Vallabhaneni
Journal:  MMWR Surveill Summ       Date:  2019-09-27

9.  Loss of Coordinated Neutrophil Responses to the Human Fungal Pathogen, Candida albicans, in Patients With Cirrhosis.

Authors:  Sally A I Knooihuizen; Natalie J Alexander; Alex Hopke; Nicolas Barros; Adam Viens; Allison Scherer; Natalie J Atallah; Zeina Dagher; Daniel Irimia; Raymond T Chung; Michael K Mansour
Journal:  Hepatol Commun       Date:  2021-01-05

10.  Spleen Tyrosine Kinase Is a Critical Regulator of Neutrophil Responses to Candida Species.

Authors:  Paige E Negoro; Shuying Xu; Zeina Dagher; Alex Hopke; Jennifer L Reedy; Michael B Feldman; Nida S Khan; Adam L Viens; Natalie J Alexander; Natalie J Atallah; Allison K Scherer; Richard A Dutko; Jane Jeffery; John F Kernien; J Scott Fites; Jeniel E Nett; Bruce S Klein; Jatin M Vyas; Daniel Irimia; David B Sykes; Michael K Mansour
Journal:  mBio       Date:  2020-05-12       Impact factor: 7.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.